Emily Brown
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 25, 2022
Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy?Dalal Y Al-Bazz, Andrew J Nelson, Jamie Burgess
|Jul 21, 2021
A <u>r</u>andomis<u>e</u>d, controlled, double blind <u>s</u>tudy to assess mechan<u>i</u>stic effects of combination therapy of dapag<u>li</u>flozin with <u>e</u>xenatide QW versus dapagliflozin alone i<u>n</u> obese patients with <u>t</u>ype 2 diabetes mellitus (RESILIENT): study protocol.Emily Brown, Moon M Wilton, Victoria S Sprung
|Jul 04, 2020
Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes.T J Hydes, N Summers, E Brown
|Apr 12, 2019
Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities.Emily Brown, John P H Wilding, Thomas M Barber
|Oct 23, 2018
Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood.Daniel J Cuthbertson, Emily Brown, Juha Koskinen
|Dec 06, 2017
Multidisciplinary management of refractory insulinomas.Emily Brown, Daniel Watkin, Jonathan Evans
Pageof 1
